Basel
Switzerland
19
2022-12-22
The entities that hold a legal rights for patent applications filed by inventor Lane Heidi:
Heidi Lane from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
1,2,4-OXADIAZOL-5-ONE DERIVATIVES FOR THE TREATMENT OF CANCER
#2 | 2022-11-24PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES
#3 | 2022-02-03PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES
#4 | 2020-12-17Pharmaceutical combinations for use in the treatment of neoplastic diseases
#5 | 2020-01-30SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE
#6 | 2019-05-16MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS
#7 | 2018-10-25USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE
#8 | 2018-01-04Substituted mono- and polyazanaphthalene derivatives and their use
#9 | 2016-10-20TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#10 | 2014-04-17TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#11 | 2013-11-07TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#12 | 2013-10-31Treatment of solid tumors with rapamycin derivatives
#13 | 2013-09-26TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#14 | 2013-09-19TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#15 | 2013-04-02Cancer treatment
#16 | 2013-03-07TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES
#17 | 2012-11-08Treatment of solid tumors with rapamycin derivatives
#18 | 2012-08-23Treatment of solid tumors with rapamycin derivatives
#19 | 2008-09-04BIOMARKERS FOR SENSITIVITY OF PROLIFERATIVE DISEASES TO MTOR INHIBITORS
129094 ⎘